Medtronic Records 38% Dip -- Firm Cites 1q Restructuring, Litigation for Earnings Decline; but Major Growth Is Forecast
The Commercial Appeal (2007-Current) › August 26, 2009
Linked as:
Summary
Charges related to patent litigation and restructuring sent Medtronic Inc. earnings down 38 percent in the first quarter to $445 million.
The company paid $444 million in the quarter to heart stent competitors Abbott Laboratories and evYsio Medical Devices LLC.See the full content of this document
Extract
Medtronic Records 38% Dip -- Firm Cites 1q Restructuring, Litigation for Earnings Decline; but Major Growth Is Forecast
The companies agreed to cross-license the stent patent and not sue each other for the next 10 years, accordin...
See the full content of this document
Sponsored links
